← Ишга қайтиш
Ушбу ишга иқтибос қилган ишлар
2 та иш
Иш: Safety and immunogenicity of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine in two formulations: two open, non-randomised phase 1/2 studies from Russia
Маҳсулотлар
Ишлаб чиқувчилар учун
AkademBaseЭкотизим учун очиқ API2 та иш
Иш: Safety and immunogenicity of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine in two formulations: two open, non-randomised phase 1/2 studies from Russia